Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
Clinical trial NCT01022996 · COMPLETED
Trial details
- NCT number
- NCT01022996
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-11-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.